TNF and Sepsis: Rice et al. [68] evaluated CytoFab, an affinity-purified polyclonal ovine anti–TNF-α IgG Fab fragment, in 81 severe sepsis patients (43 CytoFab, 38 placebo) in a double-blind, placebo-controlled multicenter phase II trial.